Histocompatibility 2, class II antigen A, beta 1 (H2-Ab1)

H2-Ab1 (Histocompatibility 2, class II antigen A, beta 1) is a mouse gene that encodes the beta chain of the MHC class II (I-A) molecule, serving as the functional ortholog to the human HLA-DQB1 [1, 3]. This protein is a vital component of the adaptive immune system, primarily expressed on professional antigen-presenting cells (APCs) such as dendritic cells, B cells, and macrophages [6]. Its core biological function involves the binding and presentation of exogenous peptide antigens to CD4+ T-cell receptors, which is essential for T-cell activation and the orchestration of immune responses [2, 5]. H2-Ab1 is critically linked to the development of various autoimmune diseases, including type 1 diabetes and multiple sclerosis models, where it may present self-antigens to autoreactive T cells [1, 4]. Additionally, it plays a key role in the immune defense against bacterial and viral pathogens and is often a focus in cancer immunology research [2, 9]. In the pharmaceutical context, H2-Ab1 is a target for immunomodulatory therapies like glatiramer acetate, which competes for MHC II binding sites, and its expression is regulated by cytokines such as interferon-gamma [4]. Its deficiency is also strategically utilized in specialized immunodeficient mouse models to prevent graft-versus-host disease (GvHD) during human immune system reconstitution [6].

Other names

A betaAbetaH2-AbH-2AbIa-2Ia2I-AbIAbI-AbetaRmcs1

Antigen presentation to CD4+ T cells, competitive binding to MHC class II molecules, and modulation of MHC class II surface expression [2, 4, 6].